AFMD(Delisted)
Affimed·NASDAQ
--
--(--)
AFMD Profile
Affimed N.V.
A clinical-stage immuno-oncology company that develops therapeutics for cancer
Gottlieb-Daimler-Straβe 2, 68165 Mannheim, Germany
--
Affimed N.V. was established as a holding company in the Netherlands in May 2014. The company is a clinical-stage biopharmaceutical company dedicated to the discovery and development of highly targeted cancer immunotherapies. The development of the company's product candidates in the field of immuno-oncology represents an innovative approach to cancer therapy that aims to harness the body's own immune system against tumor cells.
